Contact

SyndicateNL of the Netherlands was founded in 2020 and is headquartered in Wageningen University and Research Center in the Netherlands, Europe. The company focuses on the research, development and production of pharmaceuticals, health products, medical cosmetology, cosmetics, cancer research and genetically controlled plant products. The company introduces and breeds seed sources, and plants, produces and processes industrial hemp raw materials in legal regions around the world. It is currently actively expanding international market channels, developing an international supply chain for industrial hemp raw materials and sales of industrial hemp branded consumer packaged goods and retail experience products in Asia, Africa, Europe and the Americas. At the same time, the company is actively participating in international institutional cooperation and conducting clinical research on industrial hemp extract medicine.

Nordic ÖU Syndicatenl Cannabidiol Pharmaceutical company, was founded in 2024 and headquartered in Tallinn, the capital of Estonia, the Nordic European company, the company focuses on the global market commercialization of small molecule biopharmaceutical research and development based on cannabidiol CBD ingredients, medical beauty product development, health care product research and development.

 

Syndicate NL B.V., Han Investment B.V., M&Z Europe B.V. Founder & CTO


ÖU Syndicatenl Cannabidiol Pharmaceutical Founder & CEO
Syndicate NL B.V Co-Founder & CEO
Focus on the global market commercialization of small molecule biopharmaceutical research and development based on cannabidiol CBD ingredients, medical product and cosmetic plastic surgery product development, health product research and development, and other commercialization of  related products and R&D.

Get in touch with us to explore our latest products and services.